In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By End Use (Hospitals, Laboratory), By Application, By Technology (Molecular Diagnostics), By Region, And Segment Forecasts, 2025 - 2030

In Vitro Diagnostic Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 150.13 billion in 2030 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights

• The IVD market demonstrates a high degree of innovation, driven by advancements in molecular diagnostics, next-generation sequencing (NGS), and point-of-care testing.
• The distribution channels for in vitro diagnostics (IVD) market play a critical role in how products reach healthcare facilities, laboratories, and End Users, impacting market reach and operational efficiency
• The pricing of In vitro diagnostics (IVD) products varies significantly based on product type, complexity, and application.
• Reagents held the largest share of 65.54% of the in vitro diagnostics market in 2024, driven by significant R&D efforts from leading market players aiming to develop innovative biomarker kits
• North America dominated the in vitro diagnostics industry and accounted for a 47.43% share in 2024